Cellular reprogramming by protein degradation: The next frontier in cancer immunotherapy
{{output}}
In this issue of Cell Chemical Biology, Lane et al.1 introduce a transgene-based system to express fusion proteins that recruit transcription factors to E3 ligases. This approach expands the target repertoire for engineered cell therapies as exemplified by the... ...
